Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As
Klonalität:
Monoclonal
Klon-Bezeichnung:
[46E3]
Isotyp:
Rabbit IgG
Reinheit:
Protein A chromatography
Formulierung:
Purified
Formel:
0.5 mg/ml, lyophilized with PBS, pH 7.4, containing 1% BSA and 0.02% sodium azide.
Application Verdünnung:
ELISA detection: 0.01-0.05 µg/ml
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
